This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
-
Page/Page column 91; 92
(2008/06/13)
More Articles about upstream products of 284463-96-3